August 5, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the significant enhancement of its commercial leadership team with the successful recruitment of two veterans of the medical device, surgical robotics and electrophysiology fields.
Joining Stereotaxis are experienced commercial leaders with relevant and complementary expertise:
August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a heart-assisting device have a lower
August 4, 2022 — The Heart Rhythm Society (HRS) is a professional society representing a diverse population of healthcare professionals providing care for patients with heart rhythm disorders. While HRS members may hold a wide variety of viewpoints on social and political issues, the Society is united in its vision of ending death and suffering due to heart rhythm disorders. The pursuit of this mission is foc
August 2, 2022 — An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition ‘
August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about 40,000 U.S. births each year, but how these particular birth defects come about is largely unknown.
